Isotopic characterisation of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethylamphetamine (ecstasy)
James F. Carter, Emma L. Titterton, Martin Murray, Richard Sleeman
The Analyst May 14, 2002 DOI: 10.1039/b201496n (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Methodological study Peer reviewed |
|---|---|
| Topics | MDMA |
| Keywords | Active ingredient Fingerprint computing Stereochemistry |
| Citations | 70 |
| Key points | Combined isotopic analysis of MDA and MDMA from seized ecstasy tablets provides a fingerprint that can link individual tablets to a common batch. |
Abstract
Combined delta2H, delta13C and delta15N isotopic analysis of MDA and MDMA extracted from seized "ecstasy" tablets provides an isotopic "fingerprint" of the active ingredient allowing individual tablets to be linked to a common batch. Correlating these data with 2H NMR analysis of the extracts has the potential to study both the natural precursor materials and synthetic pathways used in the preparation of MDA and N-substituted homologues.
Citations in the library
Cited by 3
- A Review of Recent Advances in Impurity Profiling of Illicit MDMA Samples Journal of Forensic Sciences October 18, 2007
- Hypothetical biosynthetic pathways of pharmaceutically potential hallucinogenic metabolites in Myristicaceae, mechanistic convergence and co-evolutionary trends in plants and humans. Phytochemistry February 1, 2024
- Methylenendioxyamphetamine produces serotonin nerve terminal loss and diminished behavioural and neurochemical responses to the antidepressant fluoxetine. European Journal of Neuroscience August 2003